Pathophysiology of heart failure / M. Velez and N.K. Sweitzer -- Medical therapy for heart failure / N.K. Lakdawala and A. Desai -- Device trials in chronic heart failure: Implications of trial design / W.K. Laskey and R. Manring-Day -- The FDA perspective on heart failure devices / M.G. Hillebrenner [and others] -- Hemodynamic monitoring in heart failure / A. Nohria and A. Bhatt -- Implantable cardioverter-defibrillators / R. Lampert and Z. Goldberger -- Cardiac resynchronization therapy / D. Frisch and P.J. Zimetbaum -- Pacing and defibrillation for atrial arrhythmias / J.M. Cooper -- Atrial fibrillation ablation / J.V. Wylie and M.E. Josephson -- Percutaneous treatment of coronary artery disease / R.J. Laham -- Percutaneous management of peripheral arterial disease / M.A. Sheikh and L.A. Garcia -- Percutaneous management of valvular heart disease / J.J. Wykrzykowska and J.P. Carrozza -- Ventricular assist devices and total artificial hearts / A. Blitz and J.C. Fang -- Device therapy for left ventricular dysfunction / C.W. Yancy.
0
SUMMARY OR ABSTRACT
Text of Note
Heart failure affects over 5 million patients in the United States alone, and is a chronic and debilitating disease. While a number of pharmacologic therapies have shown varying degrees of effectiveness, many recent advances in the treatment of heart failure has focused on device based therapies. In Device Therapy in Heart Failure, William H. Maisel and a panel of authorities on the use and implementation of device based therapies provide a comprehensive overview of the current and developing technologies that are used to treat heart failure. Individual chapters provide an in-depth analysis of devices such as CRT's and ICD's, while broader topics such as the pathophysiology of heart failure and its current medical therapies are also discussed. Additional topics include Pacing and Defibrillation for Atrial Arrhythmias, Atrial Fibrillation Ablation, and Percutaneous Treatment of Coronary Artery Disease.